| 1 |
CH0113817123 |
Bellevue Biotech DT CHF |
-1,08 % |
+18,46 % |
-0,19 |
| 2 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-3,30 % |
+17,40 % |
-0,33 |
| 3 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-3,17 % |
+16,47 % |
-0,34 |
| 4 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-9,42 % |
+24,04 % |
-0,49 |
| 5 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,62 % |
+18,46 % |
-0,38 |
|
|
| 63 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-6,79 % |
+10,66 % |
-0,86 |
|
|
| 73 |
LU1803069274 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) EUR-H1 |
-16,33 % |
+19,45 % |
-0,96 |
| 74 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-16,82 % |
+18,20 % |
-1,05 |
| 75 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-18,44 % |
+19,48 % |
-1,07 |
| 76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-37,22 % |
+29,81 % |
-1,33 |
| 77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-37,30 % |
+29,80 % |
-1,33 |